Search Results
Looking for product information? Go to the HPRA website
Showing 3 from 3 results
Teva welcomes Medicines for Ireland’s report into Value Added Medicines
‘Value Added Medicines’ could offer a wide range of improvements and benefits for patients, healthcare professionals and the HSE.
The bottom line on generics in Ireland
The use of pharmaceutical generics can increase cost-effectiveness and efficiency in health care provision and spending. Learn more.
Generic Medicines in Ireland
In 2013, Ireland introduced compulsory generic medicines substitution into the country and now, five years on, we’re seeing the real economic impact of that initiative. Learn more
Date of preparation: October 2023
Reference: COB-IE-NP-00016 (V8.0)